mRNA |
BRD-K99584050 |
CTRPv2 |
pan-cancer |
AAC |
-0.047 |
0.4 |
mRNA |
tosedostat |
CTRPv2 |
pan-cancer |
AAC |
0.033 |
0.4 |
mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
0.029 |
0.4 |
mRNA |
GDC-0941 |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.4 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.033 |
0.4 |
mRNA |
BMS-270394 |
CTRPv2 |
pan-cancer |
AAC |
0.033 |
0.4 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.03 |
0.4 |
mRNA |
BRD-K44224150 |
CTRPv2 |
pan-cancer |
AAC |
0.066 |
0.4 |
mRNA |
CD-1530 |
CTRPv2 |
pan-cancer |
AAC |
0.033 |
0.4 |
mRNA |
PF-3758309 |
CTRPv2 |
pan-cancer |
AAC |
0.039 |
0.4 |